Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
27.66
+5.33 (23.87%)
At close: Oct 9, 2026, 4:00 PM EDT
27.90
+0.24 (0.88%)
After-hours: Oct 9, 2026, 7:38 PM EDT
Cue Biopharma Market Cap
Cue Biopharma has a market cap or net worth of $200.93 million as of October 9, 2026. It is the 20,904th most valuable company in the world and the 3,610th biggest in the United States. Its market cap has increased by 204.91% in one year.
Market Cap
200.93M
Enterprise Value
186.60M
1-Year Change
204.91%
Global Rank
Country Rank
#3,610 United States
Category
ChartMarket Cap Chart
Since January 2, 2018, Cue Biopharma's market cap has increased from $193.50M to $200.93M, an increase of 3.84%. That is a compound annual growth rate of 0.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 200.93M | 737.22% |
| Dec 31, 2025 | 24.00M | -65.27% |
| Dec 31, 2024 | 69.10M | -41.98% |
| Dec 29, 2023 | 119.10M | 18.15% |
| Dec 30, 2022 | 100.80M | -71.94% |
| Dec 31, 2021 | 359.20M | -5.17% |
| Dec 31, 2020 | 378.80M | 3.78% |
| Dec 31, 2019 | 365.00M | 285.84% |
| Dec 31, 2018 | 94.60M | -51.11% |
| Jan 2, 2018 | 193.50M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cartesian Therapeutics | 213.45M |
| Lyell Immunopharma | 213.44M |
| Invivyd | 212.58M |
| Entrada Therapeutics | 204.44M |
| Compugen | 201.76M |
| Eledon Pharmaceuticals | 201.73M |
| Whitehawk Therapeutics | 200.67M |
| Alpha Cognition | 196.87M |